You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR DUVELISIB

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for DUVELISIB

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01476657 ↗	A Phase 1 Study of Duvelisib in Patients With Advanced Hematologic Malignancies	Terminated	Infinity Pharmaceuticals, Inc.	Phase 1	2011-10-01	The purpose of this study is to determine the safety, maximum tolerated dose and pharmacokinetics of IPI-145 in patients with advanced hematologic malignancies.
NCT01476657 ↗	A Phase 1 Study of Duvelisib in Patients With Advanced Hematologic Malignancies	Terminated	SecuraBio	Phase 1	2011-10-01	The purpose of this study is to determine the safety, maximum tolerated dose and pharmacokinetics of IPI-145 in patients with advanced hematologic malignancies.
NCT01653756 ↗	A Phase 2a, Efficacy and Safety Study of Duvelisib in Mild Asthmatic Subjects	Completed	Infinity Pharmaceuticals, Inc.	Phase 2	2012-07-01	The purpose of this study is to examine the effects of multi-dose regimens of IPI-145 on lung function in mild asthmatic subjects following allergen challenge.
NCT01653756 ↗	A Phase 2a, Efficacy and Safety Study of Duvelisib in Mild Asthmatic Subjects	Completed	SecuraBio	Phase 2	2012-07-01	The purpose of this study is to examine the effects of multi-dose regimens of IPI-145 on lung function in mild asthmatic subjects following allergen challenge.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for DUVELISIB

Condition Name

Chart
Table

Condition Name for DUVELISIB
Intervention	Trials
Chronic Lymphocytic Leukemia	7
Small Lymphocytic Lymphoma	6
Lymphoma	4
Non-hodgkin Lymphoma	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for DUVELISIB
Intervention	Trials
Lymphoma	25
Leukemia, Lymphocytic, Chronic, B-Cell	11
Leukemia, Lymphoid	10
Leukemia	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for DUVELISIB

Trials by Country

Map
Table

Trials by Country for DUVELISIB
Location	Trials
United States	141
Italy	9
Mexico	8
United Kingdom	7
Germany	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for DUVELISIB
Location	Trials
Missouri	11
Massachusetts	11
Florida	11
New York	11
California	9
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for DUVELISIB

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for DUVELISIB
Clinical Trial Phase	Trials
Phase 3	4
Phase 2	16
Phase 1/Phase 2	6
[disabled in preview]	15
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for DUVELISIB
Clinical Trial Phase	Trials
Recruiting	16
Completed	9
Not yet recruiting	5
[disabled in preview]	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DUVELISIB

Sponsor Name

Chart
Table

Sponsor Name for DUVELISIB
Sponsor	Trials
SecuraBio	20
Infinity Pharmaceuticals, Inc.	17
Verastem, Inc.	7
[disabled in preview]	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for DUVELISIB
Sponsor	Trials
Industry	55
Other	23
NIH	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.